Natural Killer (NK) cells attack normal hematopoietic cells that do not express inhibitory MHC class I (MHC-I) molecules, but the ligands that activate NK cells remain incompletely defined. Here we show that the expression of the Signaling Lymphocyte Activation Molecule (SLAM) family members CD48 and Ly9 (CD229) by MHC-I-deficient tumor cells significantly contributes to NK cell activation. When NK cells develop in the presence of T cells or B cells that lack inhibitory MHC-I but express activating CD48 and Ly9 ligands, the NK cells' ability to respond to MHC-I-deficient tumor cells is severely compromised. In this situation, NK cells express normal levels of the corresponding activation receptors 2B4 (CD244) and Ly9 but these receptors are non-functional. This provides a partial explanation for the tolerance of NK cells to MHC-I-deficient cells in vivo. Activating signaling via 2B4 is restored when MHC-I-deficient T cells are removed, indicating that interactions with MHC-I-deficient T cells dominantly, but not permanently, impair the function of the 2B4 NK cell activation receptor. These data identify an important role of SLAM family receptors for NK cell mediated "missing-self" reactivity and suggest that NK cell tolerance in MHC-I mosaic mice is in part explained by an acquired dysfunction of SLAM family receptors.
Introduction
NK cells identify diseased target cells using a dual receptor system, which is based on arrays of activating and inhibitory cell surface receptors. Many inhibitory receptors, including Ly49 receptors in mice, killer cell immunoglobulin-like receptors (KIR) in humans and CD94/ NKG2A in both species, are specific for MHC class I (MHC-I) molecules. These receptors counteract NK cell activation as long as cells express MHC-I molecules. Aberrant cells, such as tumor cells or virally infected that have lost MHC-I molecules are more susceptible to NK cell mediated attack or "missing-self" recognition. Indeed, the absence of MHC-I molecules is sufficient to render otherwise normal cells susceptible to attack although that seems to be restricted to cells of hematopoietic origin [1] [2] [3] . These findings provide evidence that normal hematopoietic cells activate NK cells. However the activating ligands, which confer missing-self recognition have remained poorly characterized.
The absence of knowledge regarding the relevant activation receptors has also hampered progress in understanding NK cell tolerance. NK cells do not attack normal hematopoietic cells that express MHC-I thanks to the action of inhibitory receptors specific for MHC-I molecules. However not all NK cells express inhibitory MHC-I receptors [4] . These NK cells respond poorly to stimulation via several activating receptors [4, 5] , indicating that tolerance is based on impaired NK cell activation signaling. Similarly, NK cell activation signaling is compromised when NK cells develop in the complete absence of MHC-I. However, the activation receptors commonly tested do either not recognize normal cells (e.g. NKG2D) [6] or it is not known whether normal cells express ligands (e.g. NK1.1), indicating that these receptors are of questionable relevance to understand NK cell tolerance to normal self-cells. The expression and function of relevant activation receptors i.e. those mediating NK cell activation in response to normal cells is currently not known.
Key insights into the reactivity and tolerance of NK cells have been obtained using MHC-I deficient and transgenic mice [7, 8] We considered a role for Signaling Lymphocyte Activation Molecules (SLAM) family receptors as possible mediators of "missing-self" recognition since SLAM family members are solely expressed on hematopoietic cells. SLAM family molecules include SLAM (CD150, Slamf1), CD48 (Slamf2), Ly9 (CD229, Slamf3) 2B4 (CD244, Slamf4), CD84 (Slamf5), Ly108 (or NK-, Tand B-cell antigen (NTBA) in human) (CD352, Slamf6) and CRACC (CD2-like receptor activating cytotoxic cells) also termed CS1 (CD319, Slamf7). They generally mediate homotypic interactions, except 2B4, which recognizes CD48 (for review see [11] ). Engagement of SLAM family receptors with ligands ectopically expressed on target cells has provided evidence that certain receptors activate wild type NK cells [12] . In addition, 2B4/CD48 interactions promote NK cell-NK cell contacts, which enhance NK cell function [13, 14] . Paradoxically, however, the analysis of NK cells from 2B4-deficient mice suggested that 2B4 is mainly an inhibitory rather than an activating receptor [15] . On the other hand the function of CRACC-deficient NK cells was reduced, indicating that CRACC is an activating NK cells receptor [16] . Redundancy and/or opposing roles of SLAM family receptors may mask their overall importance for target cell recognition. This issue has been difficult to address using classical gene knock out since Slam family genes are tightly linked on mouse chromosome 1. Indeed, T cells, B cells and NK cells express multiple SLAM family molecules [12] . Here we have addressed a possible redundant role of SLAM family molecules for the activation of wild type NK cells in response to "missing-self" targets. We further tested the functionality of relevant receptors in NK cells from MHC-I-deficient and mosaic mice to see whether their activity can explain self-tolerance. ), stably transfected with the indicated SLAM family members or an empty pSRα control plasmid [12] were provided by A.V. RMA cells (H-2 b ) originated from a Rauscher virus-induced C57BL/6 T-cell lymphoma [19] and RMA-S, a subline of RMA with low MHC class I surface expression [20] , were electroporated with CRISPR vectors together with a plasmid encoding GFP at a ratio of 10:1. GFP+ cells were flow sorted after 24h and CD48 and Ly9 negative cells were obtained by Ab staining and flow sorting 6 days later.
Materials and Methods

Mice
For CRISPR the following sequences were cloned into Lenti CRISPR v2, a gift from Feng Zhang (Addgene plasmid # 52961) [21] .
CD48: CACCGCCCTTGGGAACTGGATTTCAGTTT, Ly9: CACCGATTCTTGGATTTTCAGAGAGGTTT EGFP: CACCGGTGAACCGCATCGAGCTGAGTTT
NK cell assays
Mice were primed by i.p. injection of 100 μg of polyinosinic-polycytidylic acid (poly I:C) (Invivogen) and spleens were harvested 24h later. Single cell suspensions were exposed for 4h to RMA or RMA/S cells, to confluent layers of B16 transfectants, or stimulated for 5h with NK1.1 mAb (PK136) coated plates or with phorbol 12-myristate 13-acetate (PMA) (50 ng/mL) and ionomycin (1 μg/mL). Lamp-1 (CD107) mAb was added at the initiation of the cultures and Golgi-Plug and Golgi-Stop was added 1 h later.
For rejection experiments mice were primed (as described above), 24h before injecting i. Spleen cells from naive mice were passed through nylon wool columns to obtain combined NK cell plus T cell preparations. NK cells were purified using an NK cell enrichment kit (STEMCell). These cell preparations were cultured in complete DMEM supplemented with Glutamine, 10% FCS, 10 mM HEPES, 50 μM β-mercaptoethanol, and 0.5 μg/mL rhuIL-2 (a gift of N. Rufer, University of Lausanne). After 5 days, the purity of NK cells was around 50% for NK + T cell cultures and >80% for purified NK cells with <10% contaminating T cells. The cells were stimulated by addition to B16 transfectants as described above.
Flow cytometry
Freshly isolated splenocytes or cultured cells were incubated with mAb 2.4G2 (CD16/32) hybridoma supernatant before staining with mixtures of biotin-labeled Ly49A (JR9-318) and a pool of FITC-labeled Ly49C/E (4D12: Note Ly49E is expressed by <1% of adult NK cells [22] ; Ly49I (YLI90) and NKG2A/C/E (20D5) NK1-1-PercpCy5.5, CD3-APC and CD19-APCCy7, followed by streptavidine-AF700. SLAM expression was detected using PE-labeled antibodies to CD244 (0224F4), CD48 (HM48-1), Ly108 (13G3-19D), Ly9 (002) and CRACC (003), CD84 (mCD84.7) or Alexa-647 anti-SLAM (TC15-12F12-2) (Biolegend). MHC-I expression was detected using APC conjugated mAbs to H-2K b (B8.24) and H-2D b (B22/249). For intracellular staining, surface-labeled cells were fixed and permeabilized (Intracellular Fixation and Permeabilization Buffer Set) followed by staining with IFNγ (XMG1.2) mAb (eBioscience). Cells were run on a LSRII flow cytometer and analyzed with Flowjo10 software.
Statistical analysis
For comparisons between two groups, statistical significance was determined using two-tailed Student t test with equal sample variance while a one-way ANOVA test with Bonferroni's multiple comparison test was used for multiple comparison groups, as indicated in the figure legends.
Results
Expression of SLAM family receptors by lymphocytes
To address which SLAM family receptors contribute to the activation of NK cells by lymphocytes we determined their expression by NK cells as well as T and B cells from naive and poly(I: C) primed mice. NK cells from naive mice expressed high levels of 2B4, Ly9 and CD84, while Ly108 was expressed by a subset of NK cells and CRACC and SLAM were not detected (S1 [12] . In contrast, we failed to see significant activation by Ly108 (S2 Fig) , and CD84 had previously been shown to not activate NK cells [12] . Thus, combined with the expression analyses, normal T cells have the potential to activate NK cells using CD48-2B4 and Ly9-Ly9 interactions while activation by B cells may further involve CRACC-CRACC interactions.
SLAM family receptors contribute to NK cell missing self-recognition
To address the importance of SLAM family receptors for missing-self recognition we used H-2 b low RMA/S thymoma cells, which activate NK cells. These cells serve as an appropriate model for missing-self recognition since parental RMA cells, which are H-2 b+ , are resistant to NK cells. Similar to normal T cells, both cell lines expressed high levels of CD48, Ly9 and CD84 while CRACC, Ly108 and SLAM were very low or absent (S1 Fig). To test whether CD48 (Slamf2) and Ly9 (Slamf3) contribute to NK cell activation, we disrupted the respective genes in RMA/S and parental RMA cells using CRISPR technology (Fig 1A) . Loss of CD48 and Ly9 expression did not alter the expression of H-2K b (Fig 1A) or H-2D b or induce SLAM family members that are normally not expressed by these cells, such as CRACC (not shown). When NK cells from primed mice were exposed to RMA/S cells lacking CD48 and Ly9 the production of IFNγ and release of Lamp-1 was significantly reduced as compared to stimulation with RMA/S control cells (Fig 1B) . NK cell mediated lysis of RMA/S cells lacking CD48 and Ly9 was also reduced (Fig 1C) . Further, in vivo experiments showed that the rejection of RMA/ S cells lacking CD48 and Ly9 was significantly lower than that of RMA/S control cells ( Fig 1D) . Inactivation of CD48 and Ly9 in parental RMA cells resulted in further reductions in the already low NK cell activation (Fig 1A-1C) , indicating that CD48 and Ly9 also contribute to NK cell activation in the case of MHC-I-expressing cells. We conclude that CD48 and Ly9 significantly contribute to NK cell activation in response to a classical "missing-self" tumor target cell.
The function of SLAM family receptors is influenced by MHC-I recognition
The functionality of activating receptors depends on the NK cell's ability to sense MHC-I using inhibitory receptors [4, 5] . However, the activating receptors commonly tested in these assays, are either of unknown relevance (NK1.1) or are not relevant (NKG2D) for the recognition of normal lymphocytes [6] . We thus addressed whether the function of SLAM receptors, which are relevant for the recognition of normal lymphocytes, is influenced by MHC-I recognition. -deficient mice responded poorly to stimulation by B16 cells expressing CD48 or Ly9 (Fig 2A) , indicating that the function of SLAM family receptors was controlled by MHC-I expression. We further inves- cells, while IFNγ production was less affected (Fig 2B-2D) . 
Discussion
Here we show that the murine 2B4 and Ly9 receptors significantly contribute to NK cell activation in response to classical "missing-self" tumor target cells. The activating function of these receptors is supported by the increased activation of NK cells using B16 cells transfected with CD48 or Ly9, in agreement with [12] and the reduced activation of NK cells in response to RMA/S cells that lack CD48 and Ly9 both in vitro and in vivo. Prior work has suggested that murine 2B4 in wild type NK cells is an inhibitory receptor [15] . This was based in part on the use of a spontaneous RMA/S variant that lacked CD48. It is possible that this variant differed in additional respects from parental RMA/S cells and that this contributed to the observed outcome. In addition, this latter study used prolonged (6-10 days) culture in IL2 to generate effector NK cells, which may modify the function of the 2B4 receptor. In contrast, we and others [12] used in vivo primed NK cell preparations and find an activating role of these receptors in wild type NK cells. Our data further reveal that there exist 2B4-Ly9-independent receptor/ ligand interactions that contribute to the activation of NK cells by RMA/S cells. As these cells lack other SLAM family molecules known to activate NK cells it is possible that these latter activation signals are independent of SLAM family molecules. Based on our rejection experiments the latter mechanisms may be particularly important in vivo.
SLAM family receptors activate NK cells using small cytoplasmic SAP family adaptors (SLAM-associated protein) including SAP, EAT-2 and ERT. NK cells lacking SAP or all three SAP-family receptors are unable to mediate missing-self recognition [12] . In the absence of these adaptors, SLAM family receptors either fail to activate or undergo a switch-of-function and mediate inhibitory function. It was thus possible that these NK cells do no longer mediate missing-self recognition since SLAM family receptors inhibit the relevant NK cell activation receptors. As we removed activating SLAM family ligands from target cells we circumvent this caveat and show that defined SLAM family receptors contribute to NK cell activation in response to missing-self targets.
We further show that the responsiveness of 2B4 and Ly9 receptors is impaired when NK cells developing in the partial or complete absence of inhibitory MHC-I molecules in vivo. The impaired responsiveness of these receptors thus explains at least in part the tolerance of NK cells towards normal-self cells expressing the respective activating ligands CD48 and Ly9 while lacking inhibitory MHC-I. This hypo-responsiveness is not related to an altered expression of 2B4 and Ly9 but is likely based on membrane-proximal signaling defects since these NK cells respond normally to stimulation with PMA/Ionomycin. In addition, membrane-proximal signaling defects in hypo responsive NK cells have been shown in the case of the NK1.1 receptor [23] , although the relevance of this receptor for the recognition of normal target cells is not known. Three models can account for the MHC-I dependent changes of the function of activation receptor in NK cells [4, 5, 10, 24, 25] : In the absence of MHC-I, the activating 2B4/Ly9 self receptors may be responsible for tolerance induction via disarming i.e. chronic stimulation of NK cells via 2B4/Ly9 due to the lack of MHC-I-dependent inhibition eventually blunts the responsiveness of 2B4/Ly9. Consistent with this notion, chronic stimulation of NK cells via distinct receptors specific for non-self or stress-induced ligands has been shown to result in hyporesponsiveness [26] [27] [28] [29] [30] . Alternatively, it is possible that the responsiveness of 2B4/Ly9 is indirectly controlled, e.g. is based on an MHC-I dependent instructive mechanism that renders 2B4/Ly9 responsive to stimulation. Finally, it is possible that MHC-I recognition during NK cell development instructs NK cells to render their 2B4/Ly9 responsive to stimulation (arming) and then prevents the chronic activation of NK cells, which would reduce the responsiveness of 2B4/Ly9 (disarming). While the available data do not discriminate between these possibilities, the identification of receptors that are relevant for NK cell activation in response to normal cells should facilitate the investigation of the molecular mechanism(s) underlying NK cell reactivity and tolerance. Such investigations are important to better understand the functional properties of host-derived and donor-derived NK cells in human leukemia patients reconstituted with (semi) allogeneic hematopoietic stem cells. 
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